141 related articles for article (PubMed ID: 26115910)
21. Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
Zhu L; Wei H; Wu Y; Yang S; Xiao L; Zhang J; Peng B
Int J Biochem Cell Biol; 2012 Jul; 44(7):1139-52. PubMed ID: 22521613
[TBL] [Abstract][Full Text] [Related]
22. Thapsigargin modulates osteoclastogenesis through the regulation of RANKL-induced signaling pathways and reactive oxygen species production.
Yip KH; Zheng MH; Steer JH; Giardina TM; Han R; Lo SZ; Bakker AJ; Cassady AI; Joyce DA; Xu J
J Bone Miner Res; 2005 Aug; 20(8):1462-71. PubMed ID: 16007343
[TBL] [Abstract][Full Text] [Related]
23. The role of calmodulin in the regulation of osteoclastogenesis.
Zhang L; Feng X; McDonald JM
Endocrinology; 2003 Oct; 144(10):4536-43. PubMed ID: 12960067
[TBL] [Abstract][Full Text] [Related]
24. NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis.
Merle B; Itzstein C; Delmas PD; Chenu C
J Cell Biochem; 2003 Oct; 90(2):424-36. PubMed ID: 14505357
[TBL] [Abstract][Full Text] [Related]
25. Reactive Oxygen Species in Osteoclast Differentiation and Possible Pharmaceutical Targets of ROS-Mediated Osteoclast Diseases.
Agidigbi TS; Kim C
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336616
[TBL] [Abstract][Full Text] [Related]
26. Tetramethylpyrazine (TMP) exerts antitumor effects by inducing apoptosis and autophagy in hepatocellular carcinoma.
Cao J; Miao Q; Miao S; Bi L; Zhang S; Yang Q; Zhou X; Zhang M; Xie Y; Zhang J; Wang S
Int Immunopharmacol; 2015 May; 26(1):212-20. PubMed ID: 25841319
[TBL] [Abstract][Full Text] [Related]
27. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
Kanazawa K; Kudo A
J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
[TBL] [Abstract][Full Text] [Related]
28. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z
J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640
[TBL] [Abstract][Full Text] [Related]
29. Ormeloxifene inhibits osteoclast differentiation in parallel to downregulating RANKL-induced ROS generation and suppressing the activation of ERK and JNK in murine RAW264.7 cells.
Kharkwal G; Chandra V; Fatima I; Dwivedi A
J Mol Endocrinol; 2012 Jun; 48(3):261-70. PubMed ID: 22493142
[TBL] [Abstract][Full Text] [Related]
30. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
31. Lycopene I--effect on osteoclasts: lycopene inhibits basal and parathyroid hormone-stimulated osteoclast formation and mineral resorption mediated by reactive oxygen species in rat bone marrow cultures.
Rao LG; Krishnadev N; Banasikowska K; Rao AV
J Med Food; 2003; 6(2):69-78. PubMed ID: 12935316
[TBL] [Abstract][Full Text] [Related]
32. Cerium ion promotes the osteoclastogenesis through the induction of reactive oxygen species.
Zhou L; Tang S; Yang L; Huang X; Zou L; Huang Y; Dong S; Zhou X; Yang X
J Trace Elem Med Biol; 2019 Mar; 52():126-135. PubMed ID: 30732873
[TBL] [Abstract][Full Text] [Related]
33. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
34. BIX-01294 induces autophagy-associated cell death via EHMT2/G9a dysfunction and intracellular reactive oxygen species production.
Kim Y; Kim YS; Kim DE; Lee JS; Song JH; Kim HG; Cho DH; Jeong SY; Jin DH; Jang SJ; Seol HS; Suh YA; Lee SJ; Kim CS; Koh JY; Hwang JJ
Autophagy; 2013 Dec; 9(12):2126-39. PubMed ID: 24322755
[TBL] [Abstract][Full Text] [Related]
35. IL-4 inhibits TNF-α-mediated osteoclast formation by inhibition of RANKL expression in TNF-α-activated stromal cells and direct inhibition of TNF-α-activated osteoclast precursors via a T-cell-independent mechanism in vivo.
Fujii T; Kitaura H; Kimura K; Hakami ZW; Takano-Yamamoto T
Bone; 2012 Oct; 51(4):771-80. PubMed ID: 22776139
[TBL] [Abstract][Full Text] [Related]
36. Suppression of autophagy in osteocytes does not modify the adverse effects of glucocorticoids on cortical bone.
Piemontese M; Onal M; Xiong J; Wang Y; Almeida M; Thostenson JD; Weinstein RS; Manolagas SC; O'Brien CA
Bone; 2015 Jun; 75():18-26. PubMed ID: 25700544
[TBL] [Abstract][Full Text] [Related]
37. Steap4 plays a critical role in osteoclastogenesis in vitro by regulating cellular iron/reactive oxygen species (ROS) levels and cAMP response element-binding protein (CREB) activation.
Zhou J; Ye S; Fujiwara T; Manolagas SC; Zhao H
J Biol Chem; 2013 Oct; 288(42):30064-30074. PubMed ID: 23990467
[TBL] [Abstract][Full Text] [Related]
38. Autophagy-dependent mitochondrial function regulates osteoclast differentiation and maturation.
Aoki S; Shimizu K; Ito K
Biochem Biophys Res Commun; 2020 Jul; 527(4):874-880. PubMed ID: 32430180
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.
Quinn JM; Itoh K; Udagawa N; Hausler K; Yasuda H; Shima N; Mizuno A; Higashio K; Takahashi N; Suda T; Martin TJ; Gillespie MT
J Bone Miner Res; 2001 Oct; 16(10):1787-94. PubMed ID: 11585342
[TBL] [Abstract][Full Text] [Related]
40. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
